Skip to main content
Jennifer Longoria, PhD, ABPP-CN
Jennifer Longoria, PhD, ABPP-CN

Jennifer Longoria, PhD, ABPP-CN

Assistant Member, St. Jude Faculty

  • Pediatric Neuropsychologist
  • Board Certified in Clinical Neuropsychology

Departments

Education

Fellowship – Henry Ford Health System
Internship – Fort Worth Independent School District
PhD – Texas Woman’s University
MA – The University of Texas at San Antonio
BA – The Ohio State University

Clinical Interests

  • Cognitive outcomes in childhood cancer and genetic disorders
  • Stroke and silent infarct
  • Pre-existing risk factors (e.g., premature birth, cerebral palsy, congenital heart disease) 

Research Interests

  • Neurocognitive functioning in sickle cell disease
  • Neurocognitive factors impacting transition to adult care and adaptive functioning  

Selected Publications

Longoria JN, Wang W, Kang G, Gossett J, Krull K, King AA, Raches D, Schreiber J, Heitzer AM, Hankins JS. Neurocognitive functioning in children with sickle cell anemia and history of abnormal transcranial toppler ultrasonographyPediatric Blood and Cancer. Nov;69(11):e29943, 2022. doi: 10.1002/pbc.29943

Heitzer AM, Longoria J, Porter JS, MacArthur E, Potter B, Ding J, Gossett J, Kang G, Hankins JS. (2022). Internalizing symptoms in adolescents with sickle cell disease. Journal of Pediatric Psychology Aug 18;jsac068, 2022. doi: 10.1093/jpepsy/jsac068

Trpchevska A, Longoria J, Okhomina V, Raches D, Potter B, Kang G, Heitzer AM, Hankins JS. Adaptive functioning in children and adolescents with sickle cell disease. Journal of Pediatric Psychology Aug 12;47(8):939-951, 2022. doi: 10.1093/jpepsy/jsac024

Heitzer AM, Longoria J, Rampersaud E, Rashkin SR, Estepp JH, Okhomina VI, Wang WC, Raches D, Potter B, Steinberg MH, King AA, Kang G, Hankins J. Fetal hemoglobin modulates neurocognitive performance in sickle cell anemia. Current Research in Translational Medicine 70(3):103335, 2022. doi: 10.1016/j.retram.2022.103335

Howell KE, Heitzer AM, Longoria JN, Potter B, Wang WC, Anderson S, Kang G, Hankins JS, Porter JS. Assessment of transition readiness to predict health care utilization during transition to adult care in sickle cell disease. Expert Rev Hematol 15(12):1063-1072, 2022.

Longoria JN, Heitzer AM, Hankins JS, Trpchevska A, Porter JS. Neurocognitive risk in sickle cell disease: Utilizing neuropsychology services to manage cognitive symptoms and functional limitations. Br J Haematol 00:1-11, 2022. doi:10.1111/bjh.18041

Heitzer AM, Cohen DL, Okhomina VI, Trpchevska A, Potter B, Longoria J, Porter JS, Estepp JH, King A, Henley M, Kang G, Hankins JS. Neurocognitive functioning in preschool children with sickle cell disease. Pediatr Blood Cancer 69:e29531, 2021. doi:10.1002/pbc.29531

Longoria, J, Pugh, NL, Gordeuk, V, Hsu, LL, Treadwell, M, King, AA, Porter, J. (2021). Influence of self-reported neurocognition on instrumental activities of daily living in sickle cell disease. American Journal of Hematology, 1-11. doi: 10.1002/ajh.26315

Heitzer, AM, Longoria, J, Okhomina, V, Wang, WC, Raches, D, Potter, B, Hankins, JS. (2021). Hydroxyurea treatment and neurocognitive functioning in sickle cell disease from school age to young adulthood. British Journal of Haematology. doi: 10.1111/bjh.17687

Phillips, J. & Longoria, J. (2020). Addressing the neurodevelopmental needs of children and adolescents with congenital heart disease: A review of the existing intervention literature. Child Neuropsychology, 26(4), 433–459. doi: 10.1080/09297049.2019.1682131

Longoria J, Rodriguez BJ. Addressing disruptive behavior with response to intervention practices: A case-study approach to improving behavior in student ADHD populations. Research and Practice in the Schools 3(1):11-19, 2015.

Last update: January 2023

Close